![Karen Noël](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Noël
Directeur/Membre du Conseil chez
ABIONYX PHARMA SA
Profil
Karen Noël is an Independent Director at ABIONYX Pharma SA since 2017.
She is also a General Partner and Chief Legal Officer at Partech Partners SAS since 2017.
Previously, she worked as an Associate at Gide Loyrette Nouel and as a Partner at Morgan, Lewis & Bockius LLP.
Ms. Noël completed her undergraduate degree at ESSEC Business School and Université Paris II Panthéon Assas.
Postes actifs de Karen Noël
| Sociétés | Poste | Début |
|---|---|---|
| ABIONYX PHARMA SA | Directeur/Membre du Conseil | 09/06/2017 |
Partech Partners SAS
 Partech Partners SAS Investment ManagersFinance Partech Partners invests in companies located across the globe with revenues of EUR 1 - 100 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size ranging from EUR 0.2 to 60 million. It acts as a lead investor. | Private Equity Investor | 01/01/2017 |
Anciens postes connus de Karen Noël
| Sociétés | Poste | Fin |
|---|---|---|
Morgan, Lewis & Bockius LLP
 Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Gide Loyrette Nouel
 Gide Loyrette Nouel Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Formation de Karen Noël
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Partech Partners SAS
Partech Partners SAS Investment ManagersFinance Partech Partners invests in companies located across the globe with revenues of EUR 1 - 100 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size ranging from EUR 0.2 to 60 million. It acts as a lead investor. | Finance |
Gide Loyrette Nouel
Gide Loyrette Nouel Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris II Panthéon Assas
 Université Paris II Panthéon Assas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
